Although it remains unclear how
endogenous gonadal hormones influence bone sarcoma development, the work provides the framework for selecting a target population for bone sarcoma prevention studies.
Not exact matches
To characterize the dose - response relationship between
endogenous sex hormones and bone sarcoma risk, a study providing information on lifetime
gonadal hormone exposure would be required.
To determine whether there was an association between
endogenous sex hormones and risk of bone sarcoma, relative risk (RR) of incidence rates and hazard ratios for bone sarcoma were calculated for dogs subdivided on the basis of lifetime
gonadal hormone exposure.